Many years of trusted cooperation with oncologists and hematologists allows us to provide you consultation on the most complex problems, such as advisory board instruction. We not only take into consideration the latest and most popular names, but also aim to recognize emerging potential of young and up-and-coming oncologists. We do this because it is exactly these opinion leaders that will determine the continuing development of your products in the future.
The selection is then based on research of current publications relevant to your indications. The located names will be tested in relation to the most defining qualities of the opinion leaders in a so-called “peer review”. The result is a ranking of the most important names. This allows for assessment of the potential within the cross section of opinions in relation to the relevant target group.
Contact us to set up a detailed and tailored project!